Bioreactor technologies to support liver function in vitro
Mo R. Ebrahimkhani(University of Pittsburgh), Linda G. Griffith(Massachusetts Institute of Technology), Micha Sam Brickman Raredon(Massachusetts Institute of Technology), Jaclyn A. Shepard Neiman(Massachusetts Institute of Technology), David Hughes(CN Bio Innovations (United Kingdom))
Cited by 134
Related Papers
An enhanced CRISPR repressor for targeted mammalian gene regulation
|Nature Methods|2018|533
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
|Scientific Reports|2018|465
Cas9 gRNA engineering for genome editing, activation and repression
|Nature Methods|2015|356
Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease
|Nature Medicine|2011|212
CRISPR transcriptional repression devices and layered circuits in mammalian cells
|Nature Methods|2014|198